A-3 Amendment 0002.pdf
PDF 264 KB Posted
- Solicitation number
- HT9402-24-Q-9304
- Issued by
-
Defense Health Agency
About this file
This document is an amendment to Solicitation HT9402-24-Q-9304, issued by the Defense Health Agency. The purpose of the amendment is to update the NDC Price List for the solicitation, changing the product classification from Respiratory Interleukins to Atopy. All other terms and conditions remain the same.
The underlying solicitation is for the Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program. The solicitation is seeking pharmaceutical agents for the DoD Uniform Formulary, with a P&T Committee meeting scheduled for August 2024 to review newly approved drugs in several therapeutic classes. The RFQ, including UF BPA and UF ADP appendices, is attached. Key details include the instructions, important deadlines, and points of contact, with a pre-quotation teleconference scheduled for July 10, 2024.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A-3 Price List - Fasenra 10mg - Respiratory Interleukins - NA.xlsx | XLSX spreadsheet | |
| A-3 Price List - Fasenra 10mg - Atopy - NA.xlsx | XLSX spreadsheet | |
| A-3 Amendment 0003.pdf | ||
| A-3 Price List - Fasenra 10mg - Atopy - NA.xlsx | XLSX spreadsheet | |
| Amendment 0001 RFQ3 NAD.pdf | ||
| A-3 Price List - Fasenra 10mg - Respiratory Interleukins - NA.xlsx | XLSX spreadsheet | |
| A-3 Price List - Myhibbin - Immunosuppressive - NA.xlsx | XLSX spreadsheet | |
| A-3 Price List - Sitagliptan-Metformin - Diabetes Non-Insulin - DPP-4 Inh.xlsx | XLSX spreadsheet | |
| A-3 Price List - Iqirvo - Gastrointestinal-2 Agents - NA.xlsx | XLSX spreadsheet | |
| A-3 RFQ HT9402-24-Q-9304 NAD.pdf | ||
| A-3 Price List - Duvyzat - Corticosteroids-Immune Mods - NA.xlsx | XLSX spreadsheet | |
| A-3 Price List - Tyenne - TIBS - Non-TNFI.xlsx | XLSX spreadsheet | |
| A-3 DoD Formulary Placement of FDA Newly Approved Drugs.pdf | ||
| A-3 Price Appendix FAQ NAD.pdf |
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DEFENSE HEALTH AGENCY
7700 ARLINGTON BOULEVARD, SUITE 5101
FALLS CHURCH, VIRGINIA 22042-5101
HT9402-24-Q-9304 0002
July 9, 2024
SUBJECT: Amendment to Solicitation HT9402-24-Q-9304 to update NDC Price List.
1. The purpose of this amendment is to update the following NDC Price List for RFQ HT9402-24-Q-9304 to update the class from Respiratory Interleukins to Atopy:
FROM: A1 Price List Fasenra 10mg - Respiratory Interleukins - NA TO: A2 Price List Fasenra 10mg - Atopy - NA
1. All other terms and conditions remain the same.
Marsha L. Petersen Contracting Officer
| 2024-07-09T15:26:14-0500 | |
| PETERSEN.MARSHA.LISA.1021485299 |
File details come from the government source that posted it. Updated .